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Abstract
Purpose: To determine the appropriate number of histopathological cross-sections that are
required for a conclusive diagnosis of giant cell arteritis (GCA).
Methods: In this cross-sectional study, the number of sections per slide for paraffin-embedded
blocks for 100 randomly selected cases where GCA was suspected and those for negative
temporal artery biopsies (TABs) were compared with the number of cross-sections per specimen
for eight positive-TABs. All aforementioned examinations were conducted at our center from 2012
to 2016. Then, negative-TABswere retrieved and re-evaluated using light microscopy considering
the histopathological findings of GCA.
Results: Ninety-five paraffin blocks were retrieved. The original mean biopsy length was 15.39 ±
7.56 mm. Comparison of the mean number of cross-sections per specimen for both the positive-
and negative-TABs (9.25 ± 3.37 and 9.53 ± 2.46) showed that 9.87 ± 2.77 [95% confidence
intervals (CI)] cross-sections per specimen were sufficient for a precise GCA diagnosis. There
was no statistically significant difference in the mean biopsy length (P = 0.142) among the eight
positive-TABs. Similarly, no significant difference was observed in the number of cross-sections
per specimen (P = 0.990) for positive-TABs compared to those for the negative-TABs. After the
retrieval of negative-TABs, the mean number of total pre- and post-retrieval cross-sections per
specimen was 17.66 ± 4.43. Among all retrieved specimens, only one case (0.01%) showed the
histopathological features of healed arteritis.
Conclusion: Positive-TABs did not reveal more histological cross-sections than the negative ones
and increasing the number of cross-sections did not enhance the accuracy of TAB.
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Giant cell arteritis (GCA) is characterized by
granulomatous vasculitis of large and medium-
sized vessels, and its worldwide annual
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incidence rate ranges from 1.28 to 29.1 per
100,000 among individuals aged over 50
years.[1–3] Approximately 15–20% of GCA patients
may develop permanent loss of vision.[4] As
per the guidelines of the American College of
Rheumatologists (ACR), diagnosis of GCA is
primarily based on the presence of characteristic
clinical features and laboratory findings of
elevated levels of acute-phase reactants.[5–7]
Temporal artery biopsy (TAB) is considered as
the gold standard diagnostic test for GCA.[8, 9] A
positive-TAB test is mainly defined as vasculitis
with infiltration of mononuclear cells with or
without the presence of multinucleated giant cells,
disruption of the internal elastic lamina, and intimal
hyperplasia.[10–12] However, sometimes TAB may
indicate intermediate findings that make it difficult
to distinguish GCA from other pathologies such
as healed arteritis or even arteriosclerosis that
occurs in elderly patients.[13, 14] Thus, TAB has low
sensitivity and it may show negative results in 15–
40% of patients.[15–19] Additionally, the number of
biopsies, length of the artery sampled, sectioning
techniques, and histopathological criteria for
diagnosing arteritis, presence of skip lesions,
and previous treatment with corticosteroids may
contribute to false-negative results.[20, 21]
This study was performed at a tertiary referral
center to determine the appropriate number of
cross-sections for a TAB examination that are
required for a conclusive GCA diagnosis.
METHODS
In our center, TAB cross-sections are routinely
cut into 2–3 mm-long slices and each of them is
embedded transversely in a paraffin block. Next,
hematoxylin and eosin-stained serial sections of 5-
μm thickness are prepared at three-step levels with
25-μm intervals. TAB specimens are considered
positive if a narrow lumen, irregular intimal
thickening, and fragmentation of the internal
elastic lamina with inflammation of the vessel
wall (composed of lymphocytes and epithelioid
histiocytes with or without multinucleated giant
cells) are observed. In borderline cases including
those wherein inflammation is limited to the
adventitia, additional levels are requested. In
this cross-sectional study, the histopathology
reports of 205 archived temporal artery biopsies
(TABs; performed between 2012 and 2016) were
re-evaluated. The length of the biopsy and total
number of cross-sections per specimen for eight
positive-TAB cases were compared with those
for a 100 computer-assisted randomly selected
negative-TABs, which were performed during
the same period. Then, paraffin-embedded
blocks of these original negative-TABs were
retrieved and >90% of each paraffin block was
sectioned. A single ophthalmic pathologist
(RAAN) re-evaluated all the newly retrieved
sections, considering the previously mentioned
histopathological findings that characterize GCA.
The methods and main outcomes of the study
have been summarized in Figure 1. In addition,
the revised ACR-2016 (rACR) scores from the
available medical records of patients with positive-
and negative-TABs conducted in 2016 were
evaluated.
SPSS software version 22.0 (IBM Corp., Armonk,
NY) was used for statistical analyses. Results
are reported as mean ± standard deviation. The
Mann–Whitney U test was used to analyze
quantitative variables. P-value < 0.05 was
considered statistically significant.
RESULTS
Of the total 205 TABs conducted during 2012–
2016, eight reports were positive for GCA. From
the remaining 197 negative biopsies, initially a 100
paraffin-embedded blockswere randomly selected
for retrieval. Since five paraffin blocks were not
suitable for retrieval, finally the results of 95
specimens were evaluated.
The mean age of the patients was 62.75 ± 12.83
years and 54% were female. Two patients had non-
simultaneous bilateral biopsies. The mean biopsy
length was 15.39 ± 7.56 mm.
The number of slides per specimen, cross-
sections per slide, and the number of slides per
mm of biopsy length before and after retrieval have
been summarized in Table 1.
In the eight positive-TAB specimens, the mean
artery length was 16.70 ± 8.48 mm and the mean
number of cross-sections per specimen was 9.25
± 3.37. No statistically significant differences were
found in the biopsy length (P = 0.142) and the
number of cross-sections per specimen (P = 0.990)
among the eight positive-TABs and when the
positive TABs were compared to the pre-retrieval
negative-TABs (Table 1). Comparison of the number
of cross-sections per specimen for pre-retrieval
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Figure 1. (A) Healed arteritis: note the narrow lumen andminimal intramural lymphocytic infiltration, scarring, and fibrosis (asterisks)
in areas with destroyed elastic lamina (short arrows) compared to the areas of intact elastic lamina (long arrows), (H&E staining
×40). (B) Normal artery, negative for GCA (H&E staining ×40). (C) Active GCA: note the obstruction of the lumen, arterial wall
thickening, elastic lamina fragmentation, and intramural inflammation with multinucleated giant cells (arrow), (H&E staining ×100).
GCA, giant cell arteritis; H&E, Hematoxylin and Eosin
Mean cross-sec!ons/specimen: 9.25 ± 3.37 *                     
100 randomly selected paraffin blocks   
 
        
                            
Mean pre-retrieval cross-sec!ons/specimen: 9.53 ± 2.46 * 
Mean post-retrieval cross-sec!ons/specimen: 8.12 ± 3.09 
         Total pre- and post-retrieval cross-sec!ons/specimen: 17.66 ± 4.43      
8 posi!ve TABs 
 
197 nega!ve TABs 
95 retrievable blocks  
Total 205 TABs (2012–2016) 
1 healed arteri!s 94 nega!ve TABs 
Figure 2. Summary of the methods and main outcomes of the study.
*There was no significant difference in the mean number of cross-sections per specimen between the positive- and original
negative-TABs (P = 0.990). Based on the comparison of these two items, 9.87 ± 2.77 (95% confidence intervals) cross-sections
per specimen were considered sufficient for precise results.
In addition, retrieval of the original negative-TABs at multiple levels did not enhance the accuracy of TAB for diagnosing GCA.
GCA, giant cell arteritis; TAB, temporal artery biopsy
negative-TABs (9.53 ± 2.46) and those for the eight
positive-TABs (9.25± 3.37) showed that 9.87± 2.77
[95% confidence intervals (CI): 9.16–10.59] cross-
sections per specimen were sufficient for precise
diagnostic results.
In the clinical evaluation of 95 negative-
TABs, we only found 50 cases with complete
medical records that met the 2016 rACR
criteria,[7] and the mean overall rACR score
for these patients was 3.86 ± 1.12. In contrast,
the mean overall rACR score for the eight
patients with positive TABs in our study was
5.87.
Histopathological evaluation of retrieved
biopsies revealed only one case (0.01%) of
healed arteritis with mild intramural lymphocytic
infiltration, narrowing of the lumen, fragmentation,
and destruction of the internal elastic lamina with
scarring of the artery wall (Figure 1). This patient
had an rACR score of 3, and had undergone
bilateral TAB, with original pathology reports
showing negative results for GCA.
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Table 1. Comparison of positive- and negative-TABs (pre- and post-retrieval)









Mean biopsy length (mm) 15.39 ± 7.56 N/A 16.70 ± 8.48 P = 0.142
Mean number of
slides/specimen
3.24 ± 0.74 2.83 ± 0.96 3.25 ± 0.82 N/A
Mean number of
cross-sections/slide
2.93 ± 0.26 2.84 ± 0.39 2.87 ± 0.36 N/A
Mean number of
cross-sections/specimen




0.72 ± 0.29 N/A 0.55 ± 0.46 N/A
Mean number of total pre- and
post-retrieval
cross-sections/specimen
17.66 ± 4.43 N/A N/A
*Comparisons of positive-TABs and pre-retrieval negative-TABs
N/A, not applicable; TAB, temporal artery biopsy
DISCUSSION
Currently, no specific guidelines have been
formulated regarding the adequate number of
cross-sections needed for accurate biopsy results
of TAB specimens.
Although TAB is considered as the gold standard
test for diagnosing GCA, ambiguous findings
may lead to inconclusive diagnosis or inaccurate
results.[8, 9] The extent of sectioning, length of
the artery, and presence of skip lesions as well
as unilateral or bilateral biopsies are among the
factors that may affect TAB results.
Characteristic histopathological findings
of active GCA include pan-arteritis that is
most pronounced in media, with or without
multinucleated giant cells and fragmented internal
elastic lamina. In contrast, healed arteritis is
characterized by diffuse intimal thickening, intimal
and medial fibrosis with variable degree of
lymphocytic infiltration, loss of internal elastic
lamina, and adventitial scarring which correlates
with prior history of GCA symptoms and a higher-
than-normal erythrocyte sedimentation rate
(ESR). Increased ESR is part of the reparative
process and not considered a marker for active
arteritis.[22] However, occasionally, it may be
difficult to distinguish the aforementioned
pathology from changes resulting from aging
and atherosclerosis.[23–25]
According to the literature, routine evaluation
of TABs at multiple levels does not enhance the
diagnostic yield and is not cost-effective.[20, 26–29]
In a study conducted by Taylor et al[29] for
determining the threshold specimen length for
pathological examination and interpretation, there
was no statistically significant difference between
the number of total cross-sections per specimen
used for positive-TABs (22.3) and those for the
negative ones (21.6). In our study, there was
no statistically significant difference in the mean
biopsy length and mean number of cross-sections
per specimen for the eight positive-TABs compared
to those of the negative-TABs before retrieval.
These results indicate that diagnosis in positive-
TAB cases did not require a greater number of
cross-sections than those required in negative
ones.
Methods for the technical processing of a
temporal artery differ across centers. Some centers
examine the artery in one longitudinal section
and two transverse ones, which may be obtained
from either end of the artery if the arterial
length is sufficient.[20, 29, 30] TAB processing at our
center is performed using transverse sections
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according to a recommended protocol,[31] with
some modifications that have been described in
the Methods section.
In this study, we determined that 9.87 ± 2.77
cross-sections per specimen were sufficient to
achieve precise results at our center. Further,
additional retrieval of the negative-TAB specimens
did not increase the chances of obtaining positive
GCA results. However, additional studies are
required to determine the appropriate number of
cross-sections for a TAB evaluation.
“Skip lesions,” which are foci of discontinuous
vasculitis, are found in 8–28% of GCA-positive
biopsies.[23, 26, 32] Skip lesions are not common
in temporal arteritis, and skipped areas are
approximately 330 μm to 1 mm in length.[27]
Although the idea is controversial, it has been
suggested that a length of 5–7 mm could be the
threshold for diagnostic sensitivity of TAB.[27, 33]
This implies that even short TAB specimens
might be sufficient to visualize the histological
features of arteritis.[27] Our results indicate that
there was only one case of healed arteritis
among 95 negative-TAB cases. These results are
compatible with those of Chakrabarty et al,[20]
wherein only 1 out of 132 cases showed positive
GCA features after performing sections at multiple
levels. However, the length of the artery in our
positive case was 13 mm. The extent of the
agreement between the first and second slide
readings using the Kappa coefficient before and
after the retrieval of the negative-TAB specimens
could not be calculated due to high similarity
between the results. However, regardless of
statistical significance, there was approximately
a 98% agreement between the two readings
since 94 out of 95 negative-TAB specimens were
also negative in the second histopathological
evaluation.
In general, it is standard to perform a unilateral
TAB when GCA is clinically suspected; the
contralateral artery biopsy is done if the clinical
suspicion is high and the first biopsy is negative.[34]
Otherwise, the chance of a positive second
biopsy ranges from 5% to 9%,[35] and if the clinical
suspicion is low, a unilateral biopsy is sufficient
to rule out the diagnosis. The single biopsy after
retrieval that was positive for healed arteritis was
that of a left temporal artery from a 67-year-old
female, which was taken seven days after a
negative-GCA result from the first biopsy of the
right artery. She had been treated with intravenous
methylprednisolone for three days followed by
oral prednisolone at a dose of 1 mg/kg before
performing TAB.
In general, for cases where GCA is suspected,
immediate treatment with high-dose steroids even
before a biopsy is recommended. Since the
resolution of inflammatory infiltration is usually
slow, the chance of detecting active inflammation
is not affected by steroid therapy if the biopsy
is performed within two weeks.[36] In our case of
healed arteritis after retrieval, the specimen was
taken seven days after starting steroid therapy.
Therefore, the findings could be due to a previous
episode of GCA rather than aging-related arterial
changes.
The diagnosis of GCA does not always require
a positive-TAB, and approximately 15–40% of
patients with GCA are TAB-negative.[15–19] This
phenomenon where a high percentage of people
who have negative biopsies are diagnosed with
GCA has resulted in disagreement among neuro-
ophthalmologists and rheumatologists regarding
the criteria for GCA. It has been recommended
that TAB should be performed only for patients
with rACR scores of 3 and 4, since there is higher
variability in TAB results for other patients.[7] Among
the 95 suspected GCA cases with negative TABs,
we reviewed the medical records of 50 patients
whose mean overall rACR score was 3.86 ± 1.12.
These results were similar to those of Abri Aghdam
et al[37] (mean score of 3.88 ± 1.19 for negative
biopsies). In addition, the mean overall rACR score
of the eight patients with positive-TABs in our
study was 5.87. After retrieval of negative-TABs, we
identified only one case of healed arteritis with an
rACR score of 3.
Positron emission tomography[38] and 3
tesla-magnetic resonance imaging[39] are new
technologies that are now being regularly used
in the diagnosis and monitoring of GCA disease
progression. Although, the use of non-invasive
color duplex ultrasonography reduces the chances
of false-negative TABs due to skip lesions,[40] it is
an operator-dependent technique.
It is important to consider that the final diagnosis
in TAB-negative patients may indicate a spectrum
of conditions mainly including other rheumatologic
diseases, presence of non-temporal arteries with
GCA, infectious diseases, neoplastic diseases, and
neuro-ophthalmic conditions.[7, 41]
In conclusion, positive-TABs in our study did
not require more cross-sections than the negative
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ones. Further, TAB examination at multiple levels
did not increase the diagnostic yield of the test. In
this study, 9.87 ± 2.77 cross-sections per specimen
were sufficient for a precise diagnosis of GCA.
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